Annuncio • Feb 18
Tecsys Inc. to Report Q3, 2026 Results on Mar 04, 2026 Tecsys Inc. announced that they will report Q3, 2026 results After-Market on Mar 04, 2026 Annuncio • Nov 21
Tecsys Inc. to Report Q2, 2026 Results on Dec 03, 2025 Tecsys Inc. announced that they will report Q2, 2026 results After-Market on Dec 03, 2025 Annuncio • Nov 13
Tecsys Inc. Expands Access to Its Elite™? Supply Chain Platform Through AWS Marketplace Tecsys Inc. announced that its Elite™? platform is now available in AWS Marketplace, giving healthcare and complex distribution organizations faster, more direct access to its enterprise-grade technology. The availability of Elite™? in AWS Marketplace reflects a commitment to make enterprise supply chain solutions more accessible. Through AWS Marketplace, organizations can easily procure, deploy and manage Tecsys' cloud-based technology while benefiting from the security, scalability and simplified billing of AWS. With Tecsys' Elite™? platform, healthcare systems and complex distributors gain visibility and control across their supply chains, to improve inventory utilization, optimize fulfillment performance and enhance service quality. Built to adapt to the nuances of each customer's operation, the platform empowers organizations to configure workflows, data views and automations that reflect their unique processes. Annuncio • Aug 26
Tecsys Inc. to Report Q1, 2026 Results on Sep 04, 2025 Tecsys Inc. announced that they will report Q1, 2026 results After-Market on Sep 04, 2025 Annuncio • Jun 25
Tecsys Inc., Annual General Meeting, Sep 04, 2025 Tecsys Inc., Annual General Meeting, Sep 04, 2025. Annuncio • Jun 14
Tecsys Inc. to Report Q4, 2025 Results on Jun 26, 2025 Tecsys Inc. announced that they will report Q4, 2025 results After-Market on Jun 26, 2025 Annuncio • Mar 08
Tecsys Inc. announces Quarterly dividend, payable on April 16, 2025 Tecsys Inc. announced Quarterly dividend of CAD 0.0850 per share payable on April 16, 2025, ex-date on March 26, 2025 and record date on March 26, 2025. Annuncio • Feb 20
Tecsys Inc. to Report Q3, 2025 Results on Mar 05, 2025 Tecsys Inc. announced that they will report Q3, 2025 results After-Market on Mar 05, 2025 Annuncio • Nov 20
Tecsys Inc. to Report Q2, 2025 Results on Dec 04, 2024 Tecsys Inc. announced that they will report Q2, 2025 results After-Market on Dec 04, 2024 Recent Insider Transactions • Sep 15
Executive Chairman recently sold €533k worth of stock On the 12th of September, David Brereton sold around 20k shares on-market at roughly €26.66 per share. This transaction amounted to 2.2% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by €3.3m. Declared Dividend • Sep 11
First quarter dividend of CA$0.08 announced Shareholders will receive a dividend of CA$0.08. Ex-date: 20th September 2024 Payment date: 4th October 2024 Dividend yield will be 0.9%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is not covered by earnings (315% earnings payout ratio) nor is it adequately covered by cash flows (97% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 250% to bring the payout ratio under control. EPS is expected to grow by 82% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio. Annuncio • Sep 10
Tecsys Inc. Announces Appointment to Its Board of Directors Tecsys Inc. announced the appointment of Stephany Verstraete and Sripriya Thinagar to its Board of Directors, effective September 5, 2024. This strategic move reflects Tecsys' commitment to strengthening its leadership team and enhancing its governance as the company continues to drive innovation in the supply chain sector. Verstraete is a distinguished technology and digital healthcare executive with over two decades of experience scaling businesses and leading transformative change in highly competitive environments. Her career includes significant roles at Teladoc Health, Expedia and PepsiCo, where she has driven remarkable results across multinational teams. She has a strong background in mergers and acquisitions, brand building and cross-channel marketing. Her passion for leveraging data and advanced technologies to deliver innovative experiences and create behavioral change has been a key factor in her success . Thinagar brings over 25 years of experience in technology and operational excellence, having held senior executive roles at Olo, Manhattan Associates and Bank of America. She has a background in leading global teams across product, platform and data engineering, with experience managing complex products across diverse sectors. Her insights into the competitive landscape of supply chain management, together with her deep understanding of a SaaS technology infrastructure, will help Tecsys continue to navigate an evolving industry and enhance its operational capabilities. New Risk • Sep 06
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.9% Last year net profit margin: 2.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.9% net profit margin). Buy Or Sell Opportunity • Sep 05
Now 22% undervalued Over the last 90 days, the stock has risen 23% to €27.60. The fair value is estimated to be €35.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 40%. Annuncio • Aug 24
Tecsys Inc. to Report Q1, 2025 Results on Sep 05, 2024 Tecsys Inc. announced that they will report Q1, 2025 results After-Market on Sep 05, 2024 Reported Earnings • Jul 29
Full year 2024 earnings released: EPS: CA$0.13 (vs CA$0.14 in FY 2023) Full year 2024 results: EPS: CA$0.13 (down from CA$0.14 in FY 2023). Revenue: CA$171.2m (up 12% from FY 2023). Net income: CA$1.85m (down 12% from FY 2023). Profit margin: 1.1% (down from 1.4% in FY 2023). Revenue is forecast to grow 9.3% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Annuncio • Jul 16
Tecsys Inc. Appoints Rex Ahlstrom as Chief Strategy Officer Tecsys Inc. announced the appointment of Rex Ahlstrom as Chief Strategy Officer (CSO), effective today. Ahlstrom brings over 25 years of experience in harnessing the power of data to create business value. His background in operational leadership, data strategy and technology product management will support Tecsys as it continues to innovate and grow.Before joining Tecsys, Ahlstrom served as CTO and EVP of Innovation and Growth at Syniti where he led the global Product and Engineering organization, successfully transitioningthe company from a perpetual software business model to a SaaS product and ARR model. Prior to Syniti, Ahlstrom founded and led SOALogix, which was acquired by SAP, and built MSI Software from the ground up, achieving significant market penetration. Ahlstrom's credentials include notable roles at SAP, TeleSciences CO Systems, Defense Systems Incorporated, Westinghouse Electric Corporation and SGS Thomson, where he led numerous high-impact projects and initiatives. He is recognized as an industry expert, an IBM Champion, and a member of the MindShare Alumni Network. Ahlstrom will collaborate across the enterprise to lead global initiatives and strategic business activities that maximize the value of Tecsys' evolving SaaS offering and growing data capabilities. Ahlstrom holds a Master of Science in Electrical Engineering from The Johns Hopkins University and a Bachelor of Science in Electrical Engineering from Drexel University. Buy Or Sell Opportunity • Jul 12
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 5.4% to €24.40. The fair value is estimated to be €30.56, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 40%. Declared Dividend • Jul 04
Fourth quarter dividend of CA$0.08 announced Shareholders will receive a dividend of CA$0.08. Ex-date: 12th July 2024 Payment date: 2nd August 2024 Dividend yield will be 1.0%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is not covered by earnings (247% earnings payout ratio) nor is it covered by cash flows (111% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 174% to bring the payout ratio under control. EPS is expected to grow by 186% over the next 2 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Jun 28
Full year 2024 earnings released: EPS: CA$0.13 (vs CA$0.14 in FY 2023) Full year 2024 results: EPS: CA$0.13 (down from CA$0.14 in FY 2023). Revenue: CA$171.2m (up 12% from FY 2023). Net income: CA$1.85m (down 12% from FY 2023). Profit margin: 1.1% (down from 1.4% in FY 2023). Revenue is forecast to grow 9.7% p.a. on average during the next 2 years, compared to a 9.5% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Annuncio • Jun 26
Tecsys Inc., Annual General Meeting, Sep 05, 2024 Tecsys Inc., Annual General Meeting, Sep 05, 2024. Annuncio • Jun 19
Tecsys Inc. to Report Q4, 2024 Results on Jun 27, 2024 Tecsys Inc. announced that they will report Q4, 2024 results After-Market on Jun 27, 2024 New Risk • Apr 04
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (1.2% net profit margin). Shareholders have been diluted in the past year (2.3% increase in shares outstanding). Upcoming Dividend • Mar 13
Upcoming dividend of CA$0.08 per share Eligible shareholders must have bought the stock before 20 March 2024. Payment date: 11 April 2024. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (5.0%). Lower than average of industry peers (1.2%). Declared Dividend • Mar 11
Third quarter dividend of CA$0.08 announced Shareholders will receive a dividend of CA$0.08. Ex-date: 20th March 2024 Payment date: 11th April 2024 Dividend yield will be 0.9%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is not covered by earnings (219% earnings payout ratio). However, it is covered by cash flows (51% cash payout ratio). The dividend has increased by an average of 16% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 144% to bring the payout ratio under control. EPS is expected to grow by 118% over the next year, which means the dividend may need to be reduced to reach a sustainable payout ratio. Reported Earnings • Mar 01
Third quarter 2024 earnings released: EPS: CA$0.05 (vs CA$0.061 in 3Q 2023) Third quarter 2024 results: EPS: CA$0.05 (down from CA$0.061 in 3Q 2023). Revenue: CA$43.8m (up 13% from 3Q 2023). Net income: CA$759.0k (down 14% from 3Q 2023). Profit margin: 1.7% (down from 2.3% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Annuncio • Mar 01
Tecsys Inc. Revises Financial Guidance for Fiscal Year 2024 Tecsys Inc. is revising financial guidance for fiscal year 2024. For the period, company expects Total Revenue Growth to be 11%-14% compared to Previous Guidance was 10%-15%. Annuncio • Feb 16
Tecsys Inc. to Report Q3, 2024 Results on Feb 29, 2024 Tecsys Inc. announced that they will report Q3, 2024 results After-Market on Feb 29, 2024 Recent Insider Transactions • Dec 08
Executive Chairman recently sold €1.9m worth of stock On the 5th of December, David Brereton sold around 90k shares on-market at roughly €21.21 per share. This transaction amounted to 8.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by €6.2m. Reported Earnings • Dec 02
Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.049 profit in 2Q 2023) Second quarter 2024 results: CA$0.02 loss per share (down from CA$0.049 profit in 2Q 2023). Revenue: CA$41.5m (up 8.9% from 2Q 2023). Net loss: CA$340.0k (down 148% from profit in 2Q 2023). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.9% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings. Annuncio • Nov 29
Tecsys Inc. Announces Elite WMS for Healthcare Distribution Tecsys Inc. announced Elite WMS for Healthcare Distribution, a warehouse management system with embedded serialized DSCSA support designed for efficient and continuous compliance with DSCSA regulations as outlined by the U.S. Food and Drug Administration (FDA). Tecsys' Elite WMS for Healthcare Distribution is the industry's first warehouse management system that locally maintains full inference data on the GS1 system of standards, specifically the Serial Global Trade Item Number (SGTIN) and the Serial Shipping Container Code (SSCC). In addition to ensuring efficiency of critical warehouse functions, the system features real-time compliance and streamlined workflows for receiving, put away and fulfillment. Its unified approach eliminates the need for multiple systems to run simultaneously, avoiding dual-entry workflows. With the DSCSA mandate requiring electronic documentation of products and ownership now in effect, Elite WMS for healthcare Distribution provides wholesale pharmaceutical distributors and 3PLs a market-tested solution for regulatory adherence. Trading partner readiness extends downstream to health system and retail pharmacy clients, who must ensure upstream and downstream compliance to facilitate traceability through to the point of use. From its involvement with the Healthcare Distribution Alliance (HDA) to its participation in DSCSA serialization seminars, Tecsys continues to invest in its healthcare and pharmacy-specific supply chain traceability platform. Elite WMS for Healthcare Distribution leverages Tecsys' regulatory and compliance expertise in hospital logistics, providing the highest degree of functional maturity in the industry. This integrated DSCSA serialization compliance minimizes redundant integrations and manual record checks, enabling real-time inventory reconciliation. New Risk • Nov 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.5% average weekly change). Profit margins are more than 30% lower than last year (2.0% net profit margin). Significant insider selling over the past 3 months (€953k sold). Annuncio • Nov 21
Tecsys Inc. to Report Q2, 2024 Results on Nov 30, 2023 Tecsys Inc. announced that they will report Q2, 2024 results After-Market on Nov 30, 2023 Annuncio • Nov 14
Tecsys Inc. Appoints Andrew Kirkwood to Board of Directors, Announces Committee Realignment Tecsys Inc. announced the appointment of UK-based Andrew Kirkwood to its Board of Directors, effective October 12, 2023. Kirkwood brings a wealth of experience to Tecsys, with more than two decades of global leadership at high-growth supply chain organizations. In conjunction with Kirkwood's appointment, the Board will realign its Board committees. Drawing from his background in building global markets for supply chain technology firms, Kirkwood has a proven track record of driving both organic and inorganic growth. His deep familiarity with Tecsys' core target markets is a valuable asset. Notably, Kirkwood served as CEO at BluJay Solutions until its successful exit to E2Open in 2021. He has also held key roles at Blue Yonder (formerly JDA Software), RedPrairie and Manhattan Associates, where he contributed significantly to their growth and success. With extensive international business development experience spanning the Americas, Europe, Southern Africa, and Asia, Kirkwood has played instrumental roles in converting software businesses from a license-based model to Software as a Service (SaaS) while driving profitable growth. His leadership skills are characterized by a strong focus on strategic and market development. Kirkwood's appointment was followed by an update of Board committees as follows: The Compensation Committee is set to welcome Kirkwood, who will join Chairperson Steve Sasser and Director Vernon Lobo; Kirkwood will also join the Corporate Governance and Nominating Committee, working with Chairperson David Booth and Director Vernon Lobo; The Audit Committee will maintain its current roster, with Chairperson Kathleen Miller alongside Directors Steve Sasser and David Booth; Vernon Lobo will continue to serve as Lead Independent Director. The committee changes are effective as of November 6, 2023. Recent Insider Transactions • Oct 13
Executive Chairman recently sold €192k worth of stock On the 11th of October, David Brereton sold around 10k shares on-market at roughly €18.79 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth €515k. David has been a net seller over the last 12 months, reducing personal holdings by €4.3m. New Risk • Oct 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Profit margins are more than 30% lower than last year (2.0% net profit margin). Significant insider selling over the past 3 months (€2.1m sold). Board Change • Oct 01
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 4 highly experienced directors. Independent Director Kathy Miller was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Sep 21
Executive Chairman recently sold €79k worth of stock On the 14th of September, David Brereton sold around 4k shares on-market at roughly €20.14 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger sale from another insider worth €806k. David has been a net seller over the last 12 months, reducing personal holdings by €6.6m. Reported Earnings • Sep 08
First quarter 2024 earnings released: EPS: CA$0.08 (vs CA$0.003 in 1Q 2023) First quarter 2024 results: EPS: CA$0.08 (up from CA$0.003 in 1Q 2023). Revenue: CA$42.0m (up 23% from 1Q 2023). Net income: CA$1.17m (up CA$1.13m from 1Q 2023). Profit margin: 2.8% (up from 0.1% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 7.1% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Annuncio • Aug 26
Tecsys Inc. to Report Q1, 2024 Results on Sep 07, 2023 Tecsys Inc. announced that they will report Q1, 2024 results After-Market on Sep 07, 2023 Annuncio • Jul 21
Tecsys Inc. Appoints Vito Calabretta as Chief Customer Officer Tecsys Inc. announced the appointment of Vito Calabretta to the position of chief customer officer. Calabretta, who previously served as the senior vice president of Global Operations at Tecsys, has more than three decades of experience delivering customer-centric services at global customer-focused SaaS and services organizations including Tecsys and Accenture. As Tecsys strengthens its leadership position and expands in key industries such as complex distribution and healthcare, the appointment reaffirms the company's commitment to exceptional customer experiences and innovative supply chain optimization. During his tenure as senior vice president of Global Operations, Calabretta has been pivotal in evolving the services organization to align with Tecsys' SaaS go-to-market model. Under his leadership since 2017, customer service operations have doubled, and significant advancements have been made in areas such as project management, customer care, and professional services. His strategic initiatives have resulted in efficient delivery of services, shortened time to value and streamlined implementations. In his new role, Calabretta will be responsible for overseeing all aspects of service delivery and customer success at Tecsys. He will work cross-departmentally to ensure that customers' needs are met and that they are empowered to extract maximum value from their Tecsys software. Additionally, Calabretta will lead the development and implementation of customer-centric strategies, focusing on enhancing the customer journey, leveraging customer insights, and fostering long-term customer loyalty. Recent Insider Transactions • Jul 12
Executive Chairman recently sold €64k worth of stock On the 10th of July, David Brereton sold around 3k shares on-market at roughly €20.74 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by €6.1m. Upcoming Dividend • Jul 06
Upcoming dividend of CA$0.075 per share at 1.0% yield Eligible shareholders must have bought the stock before 13 July 2023. Payment date: 04 August 2023. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 1.0%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (1.6%). New Risk • Jun 30
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.4% Last year net profit margin: 3.3% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company. Reported Earnings • Jun 30
Full year 2023 earnings released: EPS: CA$0.14 (vs CA$0.31 in FY 2022) Full year 2023 results: EPS: CA$0.14 (down from CA$0.31 in FY 2022). Revenue: CA$152.4m (up 11% from FY 2022). Net income: CA$2.09m (down 53% from FY 2022). Profit margin: 1.4% (down from 3.3% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.8% p.a. on average during the next 2 years, compared to a 6.9% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Annuncio • Jun 24
Tecsys Inc., Annual General Meeting, Sep 07, 2023 Tecsys Inc., Annual General Meeting, Sep 07, 2023. Annuncio • Jun 17
Tecsys Inc. to Report Q4, 2023 Results on Jun 29, 2023 Tecsys Inc. announced that they will report Q4, 2023 results After-Market on Jun 29, 2023 Recent Insider Transactions • Mar 19
Executive Chairman recently sold €119k worth of stock On the 15th of March, David Brereton sold around 6k shares on-market at roughly €18.82 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. David has been a net seller over the last 12 months, reducing personal holdings by €3.4m. Upcoming Dividend • Mar 15
Upcoming dividend of CA$0.075 per share at 1.1% yield Eligible shareholders must have bought the stock before 22 March 2023. Payment date: 13 April 2023. Payout ratio and cash payout ratio are on the higher end at 98% and 86% respectively. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.8%). Lower than average of industry peers (1.9%). Reported Earnings • Mar 04
Third quarter 2023 earnings released: EPS: CA$0.06 (vs CA$0.065 in 3Q 2022) Third quarter 2023 results: EPS: CA$0.06 (down from CA$0.065 in 3Q 2022). Revenue: CA$38.9m (up 9.9% from 3Q 2022). Net income: CA$888.0k (down 5.5% from 3Q 2022). Profit margin: 2.3% (down from 2.7% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.8% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 16% per year, which means it is tracking significantly ahead of earnings growth. Annuncio • Feb 17
Tecsys Inc. to Report Q3, 2023 Results on Mar 01, 2023 Tecsys Inc. announced that they will report Q3, 2023 results on Mar 01, 2023 Annuncio • Jan 18
Tecsys Inc. Announces Warehouse-In-A-Warehouse Ecommerce Fulfillment Solution Tecsys Inc. announced how its warehouse-in-a-warehouse ecommerce fulfillment solution enables retailers and brands to execute ecommerce fulfillment flawlessly while leaving existing wholesale and distribution models and legacy systems largely intact. The warehouse-in-a-warehouse model is gaining traction as brands and retailers seek to meet the quickly evolving demands of customers and improve online order fulfillment processes by continuing to leverage existing fulfillment centers and infrastructure. It is when one facility runs multiple distribution operations that are decoupled from each other; for example, a brand owner fulfilling wholesale orders and ecommerce orders from the same location, each operation running on its own respective WMS. This strategy allows for more effective use of space and resources as it divides storage areas dedicated to ecommerce fulfillment orders destined for parcel type orders from areas designed to store pallets for case picking. The area, reserved for the ecommerce fulfillment function, is then optimized for more efficient picking, packing and shipping of online orders, allowing for faster turnaround times for ecommerce order management. This scalable approach also provides future flexibility where automation can be easily introduced into the picking and packing workflows. Tecsys recently implemented the warehouse-in-a-warehouse model for a global luxury cosmetics and beauty brand retailer seeking to drive ecommerce order fulfillment efficiency by leveraging the space in their existing fulfillment center as part of their omnichannel fulfillment strategy. The move to Tecsys' Omni(TM) WMS with available cluster picking introduced the company to digital system-automated workflows that would reduce its current ERP-driven processes by more than 90%. Reported Earnings • Dec 02
Second quarter 2023 earnings released: EPS: CA$0.049 (vs CA$0.049 in 2Q 2022) Second quarter 2023 results: EPS: CA$0.049 (in line with 2Q 2022). Revenue: CA$38.1m (up 11% from 2Q 2022). Net income: CA$715.0k (up 1.0% from 2Q 2022). Profit margin: 1.9% (down from 2.1% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 7.8% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Recent Insider Transactions • Oct 09
Executive Chairman recently sold €3.2m worth of stock On the 30th of September, David Brereton sold around 150k shares on-market at roughly €21.65 per share. This transaction amounted to 11% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was David's only on-market trade for the last 12 months. Reported Earnings • Sep 10
First quarter 2023 earnings released First quarter 2023 results: Revenue: CA$34.2m (up 2.9% from 1Q 2022). Net income: CA$40.0k (down 84% from 1Q 2022). Profit margin: 0.1% (down from 0.7% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Software industry in Germany. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Jul 07
Upcoming dividend of CA$0.07 per share Eligible shareholders must have bought the stock before 14 July 2022. Payment date: 05 August 2022. Payout ratio and cash payout ratio are on the higher end at 88% and 99% respectively. Trailing yield: 0.8%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (2.1%). Reported Earnings • Jul 01
Full year 2022 earnings released: EPS: CA$0.31 (vs CA$0.50 in FY 2021) Full year 2022 results: EPS: CA$0.31 (down from CA$0.50 in FY 2021). Revenue: CA$137.2m (up 12% from FY 2021). Net income: CA$4.48m (down 38% from FY 2021). Profit margin: 3.3% (down from 5.8% in FY 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.3%, compared to a 12% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth. Annuncio • Jun 30
Tecsys Inc. Declares Quarterly Dividend, Payable on August 5, 2022 Tecsys Inc. declared a quarterly dividend of $0.07 per share payable on August 5, 2022 to shareholders of record at the close of business on July 15, 2022. Annuncio • Jun 29
Tecsys Inc., Annual General Meeting, Sep 08, 2022 Tecsys Inc., Annual General Meeting, Sep 08, 2022. Annuncio • Jun 16
Tecsys Inc. to Report Q4, 2022 Results on Jun 29, 2022 Tecsys Inc. announced that they will report Q4, 2022 results at 4:00 PM, US Eastern Standard Time on Jun 29, 2022 Upcoming Dividend • Mar 16
Upcoming dividend of CA$0.07 per share Eligible shareholders must have bought the stock before 23 March 2022. Payment date: 14 April 2022. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (3.6%). Lower than average of industry peers (1.9%). Upcoming Dividend • Mar 16
Upcoming dividend of CA$0.07 per share Eligible shareholders must have bought the stock before 23 March 2022. Payment date: 14 April 2022. The company is paying out more than 100% of its earnings and cash flow. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (3.6%). Lower than average of industry peers (1.9%). Reported Earnings • Mar 04
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: CA$0.06 (down from CA$0.13 in 3Q 2021). Revenue: CA$35.4m (up 11% from 3Q 2021). Net income: CA$940.0k (down 49% from 3Q 2021). Profit margin: 2.7% (down from 5.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 14%, compared to a 14% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Annuncio • Mar 04
Tecsys Inc. Declares Quarterly Dividend, Payable on April 14, 2022 Tecsys Inc.'s Board of Directors declared a quarterly dividend of $0.07 per share to be paid on April 14, 2022 to shareholders of record on March 24, 2022. Annuncio • Feb 16
Tecsys Inc. to Report Q3, 2022 Results on Mar 02, 2022 Tecsys Inc. announced that they will report Q3, 2022 results on Mar 02, 2022 Annuncio • Jan 12
Tecsys' Elite™ Healthcare Software to Automate Inventory Management Tecsys Inc. announced another important milestone for its end-to-end Elite™ Healthcare supply chain execution platform with the commercialization of its automated inventory management and management insights solution for the clinical lab environment. By leveraging the robust Elite™ Healthcare software platform, this software solution builds on clinical supply chain best practices and process optimization while helping clinical labs to tackle the most common inventory challenges. Tecsys' automated inventory management for clinical labs is an intuitive technology solution designed to track, monitor, and report inventory levels and consumption within a lab environment. The solution provides unparalleled efficiency and transparency across lab-specific inventory management activities, equipping organizations to streamline workflows and optimize inventory levels while restoring clinical time spent on supply-related activities back to clinical duties. Architected to existing lab environments and site-specific conditions, the solution can be deployed across workstation and mobile interfaces, as well as leverage barcode and RFID technology. In addition to automating usage capture and demand triggers, the solution provides real-time track and traceability, automated expiry and waste management, patient specimen tracking and robust inventory optimization tools. It is built on a common platform with Tecsys' other Elite™ software products which offer complementary functionality within the broader healthcare supply chain ecosystem. Upcoming Dividend • Dec 08
Upcoming dividend of CA$0.07 per share Eligible shareholders must have bought the stock before 15 December 2021. Payment date: 07 January 2022. Payout ratio is on the higher end at 80%, however this is supported by cash flows. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (3.4%). Lower than average of industry peers (1.5%). Reported Earnings • Dec 02
Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations Second quarter 2022 results: EPS: CA$0.05 (down from CA$0.14 in 2Q 2021). Revenue: CA$34.3m (up 12% from 2Q 2021). Net income: CA$708.0k (down 66% from 2Q 2021). Profit margin: 2.1% (down from 6.8% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 13%, compared to a 34% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 63% per year. Recent Insider Transactions • Oct 02
Executive Chairman recently sold €2.7m worth of stock On the 30th of September, David Brereton sold around 70k shares on-market at roughly €37.87 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €9.4m. Executive Departure • Sep 15
Independent Director Frank Bergandi has left the company On the 10th of September, Frank Bergandi's tenure as Independent Director ended after 23.2 years in the role. As of June 2021, Frank still personally held 2.20k shares (€61k worth at the time). Frank is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 3.96 years. Reported Earnings • Sep 10
First quarter 2022 earnings released The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: CA$33.2m (up 18% from 1Q 2021). Net income: CA$244.0k (down 80% from 1Q 2021). Profit margin: 0.7% (down from 4.4% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 52% per year whereas the company’s share price has increased by 53% per year. Annuncio • Aug 25
Tecsys Bolsters Its End-to-End Elite™ Healthcare Supply Chain Execution Platform with Consolidated Pharmacy Inventory Management Tecsys Inc. announces another significant milestone to its end-to-end Elite™ Healthcare supply chain execution platform with its end-to-end consolidated pharmacy inventory management solution. Integrating unified visibility and control from the point of reception to the point of use, Tecsys' consolidated pharmacy inventory management solution extends its best-in-class consolidated service center model to pharmaceutical supplies, lending the same sophisticated warehouse, distribution and point of use orchestration software to pharmacy operations. Tecsys' consolidated pharmacy inventory management solution enables centralized strategic buying, management of pharmaceutical spend and procurement operations. By employing consolidated service center supply chain practices, the software helps to manage and mitigate drug shortages, reduces inventory and waste, and streamlines operations, all while integrating regulated processes to remain DSCSA compliant and optimize 340B programs. The pharmaceutical supply chain typically operates in parallel to medical supply management, running siloed processes to track consumption and traceability as well as manage procurement and demand planning. To address this disconnect, progressive health systems are leveraging their Tecsys-enabled consolidated service centers (CSCs) to centralize pharmacy operations and consolidate supply chain management strategies. Tecsys software is able to reconcile these discrete datasets and procurement strategies under a common platform, providing centralized control and management of all supply chain execution supplies. Consolidated management of a pharmacy's supply chain allows for cost per case and cost per procedure analyses by factoring in pharmaceutical supplies, helping hospitals to optimize reimbursement programs and enable more strategic sourcing. Tecsys' consolidated pharmacy inventory management solution is embedded within the broader Tecsys Elite™ Healthcare portfolio, which combines for the most comprehensive supply chain execution system designed specifically for the healthcare industry. Optimized for the regulatory and operational complexities involved in orchestrating multiple clinical areas with differentiated clinical demands, the system provides unified visibility and control from the point of reception to the point of use. Upcoming Dividend • Jul 08
Upcoming dividend of CA$0.065 per share Eligible shareholders must have bought the stock before 15 July 2021. Payment date: 06 August 2021. Trailing yield: 0.6%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (1.5%). Reported Earnings • Jul 03
Full year 2021 earnings released: EPS CA$0.50 (vs CA$0.18 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: CA$122.9m (up 19% from FY 2020). Net income: CA$7.19m (up 206% from FY 2020). Profit margin: 5.8% (up from 2.3% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Apr 01
CEO, President & Director recently sold €337k worth of stock On the 30th of March, Peter Brereton sold around 12k shares on-market at roughly €28.55 per share. This was the largest sale by an insider in the last 3 months. This was Peter's only on-market trade for the last 12 months. Reported Earnings • Feb 26
Third quarter 2021 earnings released: EPS CA$0.13 (vs CA$0.064 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CA$31.9m (up 21% from 3Q 2020). Net income: CA$1.85m (up 122% from 3Q 2020). Profit margin: 5.8% (up from 3.2% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 49% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Feb 26
Revenue beats expectations Revenue exceeded analyst estimates by 3.8%. Over the next year, revenue is forecast to grow 16%, compared to a 27% growth forecast for the Software industry in Germany. Annuncio • Feb 12
Tecsys Inc. to Report Q3, 2021 Results on Feb 24, 2021 Tecsys Inc. announced that they will report Q3, 2021 results on Feb 24, 2021 Is New 90 Day High Low • Feb 12
New 90-day high: €40.80 The company is up 76% from its price of €23.20 on 13 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.84 per share. Annuncio • Feb 11
Hagen Group Unleashes International Growth by Migrating to Tecsys' SaaS Supply Chain Platform Tecsys Inc. announced that Rolf C. Hagen Inc. will deploy Tecsys' SaaS software across its multinational warehouse and distribution infrastructure, fueling its continued growth against a uniquely challenging and converging marketplace. The SaaS platform will enable better operational agility and strengthen business intelligence. The Hagen Group was founded in Montreal in 1955 and has since grown into the world's largest privately owned multinational manufacturer and distributor of pet supplies. Offering over 5,000 products, and with multiple category-leading brands, the company enjoys sales in over 75 countries. As the business expands in volume and geography, priority turned to modernizing its tech stack and eliminating internal IT burden so that the continued growth of the business could be supported by the technical infrastructure in place. As with many of Tecsys' more longstanding customers, the Hagen Group sought to retain operational efficiencies and robust system capabilities while preparing for more complexity and higher demands on operational resources. A SaaS model was adopted to drive unity across disparate data siloes and complex supply chain operations in North America and Europe. Tecsys' SaaS supply chain platform enables customers to connect their core supply chain execution activities together, stitching together planning, execution and delivery capabilities from end-to-end. The Hagen Group emphasizes the importance of continued innovation and improved customer experience initiatives. The company likewise understands that staying ahead of the competitive fray is no longer just about feature, function and price. How that product reaches its destination factors fundamentally into the buying decision. By modernizing its supply chain infrastructure, functionality and capacity, the company is better positioned to focus on its core business mandate while satisfying more fastidious logistical demands. Innovation in supply chain management is fast and furious, and cloud deployment provides the backdrop to stay at the cutting edge of that innovation. Customers who convert to SaaS can harness multiple benefits like improved agility, greater security, and a better ability to absorb supply chain disruption. For over a decade, Tecsys has helped customers move their supply chains to the cloud, enabling operational elasticity and clearing the path for borderless business growth.